Pune, India, Aug. 10, 2022 (GLOBE NEWSWIRE) — The Global point of care diagnostics market Size is projected to grow during the forecast period due to the increasing incidences of infectious and chronic diseases. Fortune Business Insights™ publishes this information in a report titled, Point of Care Diagnostics Market 2029. As per the report, the point of care diagnostics market size was valued at USD 46.65 billion in 2021. The market size is expected to rise from USD 36.37 billion in 2022 to USD 51.94 billion by 2029 at a CAGR of 5.2% during the projected period.
Key Industry Development:
December 2021 – Thermo Fisher Scientific and Color Health collaborated to launch a k-12 readycheckgo covid-19 testing solution for Texas schools.
June 2020: Celltrion Group announced the SARS-CoV-2 point-of-care antigen diagnostic kit. This will help expand access to COVID-19 diagnosis management and treatment globally
Request a Sample Copy of the Global Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/point-of-care-diagnostics-market-101072
Report Scope:
| Report Coverage | Details |
| Forecast Period | 2022 to 2029 |
| Forecast Period 2022 to 2029 CAGR | 5.2% |
| 2029 Value Projection | USD 51.94 billion |
| Base Year | 2021 |
| Market Size in 2022 | USD 36.37 billion |
| Historical Data for | 2018 to 2020 |
| No. of Pages | 182 |
COVID-19 Impact:
Increasing Manufacturing Of Test Kits To…
